Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD.
Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD.
复制标题
接受 CAPD/CCPD 的儿科患者肾性骨营养不良的生化标志物。
DOI:
10.1038/ki.1994.31
复制
发表时间:
1994
影响因子:
19.6
通讯作者:
Goodman,WG
中科院分区:
文献类型:
--
作者:
Salusky,IB;Ramirez,JA;Oppenheim,W;Gales,B;Segre,GV;Goodman,WG
Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD. Serum intact PTH [1–84] levels were evaluated as a potential non-invasive method for the diagnosis of renal osteodystrophy in children treated with CAPD/CCPD. Sixty-eight bone biopsy samples were obtained from 55 patients, aged 13 ± 5 (X ±SD) years, undergoing CAPD/CCPD for 29 ± 13 months; osteitis fibrosa was present in 34 cases, mild lesions of secondary hyperparathyroidism in six, 15 had adynamic lesions, and 13 were classified as normal histology. Serum calcium levels were higher in patients with adynamic bone or normal bone histology than in those with secondary hyperparathyroidism, whereas serum phosphorus, alkaline phosphatase and PTH levels were greater in patients with osteitis fibrosa. The combination of a serum PTH level >200 pg/ml and a serum calcium value <10 mg/dl was 85% sensitive and 100% specific for identifying patients with high-turnover lesions of bone. Serum PTH values <200 pg/ml were 100% sensitive but only 79% specific for patients with adynamic bone; specificity increased to 92%, however, using the combined criteria of a PTH level <150 pg/ml and a serum calcium level >10 mg/dl. Higher serum calcium levels and serum PTH values within or below the normal range characterize patients with the adynamic lesion of renal osteodystrophy. Serum PTH levels of approximately 200 pg/ml are useful for distinguishing patients with low-turnover lesions of renal osteodystrophy from those with secondary hyperparathyroidism.
登录
查看更多内容
影响因子:
5.8
作者:
PITTS, TO;PIRAINO, BH;PUSCHETT, JB
通讯作者:
PUSCHETT, JB
DOI:
10.1210/jcem.76.6.8501155
发表时间:
1993
期刊:
The Journal of clinical endocrinology and metabolism
影响因子:
--
作者:
Ramirez,JA;Goodman,WG;Gornbein,J;Menezes,C;Moulton,L;Segre,GV;Salusky,IB
通讯作者:
Salusky,IB
影响因子:
19.6
作者:
Giulia Witmer;Alina Margolis;Olivier Fontaine;Janine Fritsch;Gérard Lenoir;Michel Broyer;Sonia Balsan
通讯作者:
Sonia Balsan
DOI:
10.1210/jcem-63-5-1163
发表时间:
1986-11
期刊:
The Journal of clinical endocrinology and metabolism
影响因子:
--
作者:
D. Andress;D. Endres;N. Maloney;J. Kopp;J. Coburn;D. Sherrard
通讯作者:
D. Andress;D. Endres;N. Maloney;J. Kopp;J. Coburn;D. Sherrard
DOI:
10.1210/jcem-39-1-119
发表时间:
1974
期刊:
The Journal of clinical endocrinology and metabolism
影响因子:
--
作者:
D. Sherrard;D. Baylink;J. Wergedal;N. Maloney
通讯作者:
N. Maloney